US Broker Ratings

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Biotech Innovator with Robust Growth Potential

Halozyme Therapeutics, Inc. (NASDAQ: HALO) is capturing investor attention in the biotechnology sector with its innovative approach to drug delivery and strong financial performance. With a market capitalization of $8.4..

Waters Corporation (WAT) Stock Analysis: Navigating Growth in Healthcare with a 32.99% ROE

Waters Corporation (NYSE: WAT), a stalwart in the healthcare sector, continues to attract attention with its robust presence in the diagnostics and research industry. Headquartered in Milford, Massachusetts, Waters Corporation..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: A Healthcare Innovator with 37% Upside Potential

Lantheus Holdings, Inc. (NASDAQ: LNTH) is a name that resonates with innovation in the healthcare sector, particularly in the niche of diagnostic and therapeutic products. With a market capitalization of..

TransMedics Group, Inc. (TMDX) Stock Analysis: A Healthcare Innovator with 32% Revenue Growth and Strong Buy Ratings

TransMedics Group, Inc. (NASDAQ: TMDX) is making waves in the healthcare sector with its groundbreaking medical devices designed to revolutionize organ transplant therapy. With a market capitalization of $5 billion,..

Option Care Health, Inc. (OPCH) Stock Analysis: Healthcare Giant with a 13.5% Upside Potential

Option Care Health, Inc. (NASDAQ: OPCH), a prominent player in the healthcare sector, particularly in medical care facilities, offers investors a compelling opportunity with a potential upside of 13.5%. The..

West Pharmaceutical Services (WST): A Healthcare Stock with a Promising 26.52% Upside

West Pharmaceutical Services, Inc. (NYSE: WST) presents itself as a compelling opportunity for investors looking to leverage growth in the healthcare sector. With a market capitalization of $19.95 billion, this..

Grifols, S.A. (GRFS) Stock Analysis: Unpacking a Potential 27% Upside in the Healthcare Sector

Grifols, S.A. (GRFS), a prominent player in the healthcare sector, has caught the attention of investors with its promising potential upside of 27.12%. As a leading plasma therapeutic company, Grifols..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: Unveiling a 59.77% Potential Upside

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a notable player in the biotechnology sector, has been making waves with its robust pipeline of therapies for rare diseases. With a market capitalization of..

Ascendis Pharma A/S (ASND) Stock Analysis: Exploring a Promising 21.67% Upside Potential

Investors looking for opportunities in the biotechnology sector might find Ascendis Pharma A/S (NASDAQ: ASND) to be a compelling option. With a market capitalization of $12.97 billion, this Denmark-based company..

Avidity Biosciences, Inc. (RNA) Stock Analysis: Is the Biotech Innovator a Buy with Its 434% Revenue Growth?

Avidity Biosciences, Inc. (NASDAQ: RNA) is capturing the attention of investors with its innovative approach in the biotechnology sector. As a leader in the development of RNA therapeutics, Avidity is..

United Therapeutics Corporation (UTHR) Stock Analysis: Aiming for Growth with a 6.64% Upside Potential

United Therapeutics Corporation (NASDAQ: UTHR), a key player in the healthcare sector, specializes in the development and commercialization of products that address the unmet medical needs of patients with chronic..

Cytokinetics, Incorporated (CYTK): Analyst Ratings Suggest 15% Upside Potential for This Biotech Innovator

Cytokinetics, Incorporated (NASDAQ: CYTK), a prominent player in the biopharmaceutical sector, is gaining investor attention with its robust pipeline of muscle activators and inhibitors aimed at treating debilitating diseases. As..

ADMA Biologics Inc (ADMA) Stock Analysis: Strong Buy Ratings and a 42% Potential Upside

ADMA Biologics Inc (NASDAQ: ADMA), a promising player in the biopharmaceutical sector, is capturing the attention of investors with its compelling growth narrative and a remarkable 42.08% potential upside. Operating..

RadNet, Inc. (RDNT)

⚠️ No article content returned.

..

Akero Therapeutics, Inc. (AKRO) Stock Analysis: Navigating the Biotech Wave with a 3% Potential Upside

Akero Therapeutics, Inc. (AKRO), a burgeoning player in the biotechnology sector, is drawing investor interest with its innovative approach to tackling serious metabolic diseases. With a market capitalization of $4.47..

DexCom, Inc. (DXCM) Stock Analysis: Poised for 32.83% Upside with Strong Buy Ratings

DexCom, Inc. (DXCM), a premier player in the healthcare sector, is making waves in the medical device industry with its cutting-edge continuous glucose monitoring (CGM) systems. Headquartered in San Diego,..

Repligen Corporation (RGEN) Stock Analysis: Navigating a 9.67% Potential Upside in the Bioprocessing Market

Repligen Corporation (NASDAQ: RGEN), a prominent player in the healthcare sector specializing in medical instruments and supplies, continues to capture investor interest with its innovative bioprocessing technologies. Headquartered in Waltham,..

Avantor, Inc. (AVTR) Stock Analysis: A Healthcare Giant with a 16% Upside Potential

Avantor, Inc. (NYSE: AVTR), a major player in the healthcare sector, is catching the attention of investors with its potential upside of 16.31%. Despite a challenging year marked by a..

Charles River Laboratories (CRL) Stock Analysis: Navigating Healthcare Diagnostics with a 6% Upside

Charles River Laboratories International, Inc. (NYSE: CRL) stands at the forefront of the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $8.77 billion, the..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Navigating Growth with a 2.74% Upside Potential

Bausch + Lomb Corporation (NYSE: BLCO), a venerable name in the healthcare sector, is a key player in the medical instruments and supplies industry. With a market capitalization of $5.73..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds